SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shuki Mizutani, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, 2015,

    CrossRef

  2. 2
    Kotoka Nakamura, Francesca Fike, Sara Haghayegh, Rachel Saunders-Pullman, Angelika J. Dawson, Thilo Dörk, Richard A. Gatti, A-TWinnipeg: Pathogenesis of rare ATM missense mutation c.6200C>A with decreased protein expression and downstream signaling, early-onset dystonia, cancer, and life-threatening radiotoxicity, Molecular Genetics & Genomic Medicine, 2014, 2, 4
  3. 3
    Luciana Chessa, Current and future therapeutic strategies to treat ataxia telangiectasia, Expert Opinion on Orphan Drugs, 2014, 2, 9, 877

    CrossRef

  4. 4
    Kavitha Siva, Giuseppina Covello, Michela A. Denti, Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases, Nucleic Acid Therapeutics, 2014, 24, 1, 69

    CrossRef

  5. 5
    Lucia Micale, Bartolomeo Augello, Claudia Maffeo, Angelo Selicorni, Federica Zucchetti, Carmela Fusco, Pasquelena De Nittis, Maria Teresa Pellico, Barbara Mandriani, Rita Fischetto, Loredana Boccone, Margherita Silengo, Elisa Biamino, Chiara Perria, Stefano Sotgiu, Gigliola Serra, Elisabetta Lapi, Marcella Neri, Alessandra Ferlini, Maria Luigia Cavaliere, Pietro Chiurazzi, Matteo Della Monica, Gioacchino Scarano, Francesca Faravelli, Paola Ferrari, Laura Mazzanti, Alba Pilotta, Maria Grazia Patricelli, Maria Francesca Bedeschi, Francesco Benedicenti, Paolo Prontera, Benedetta Toschi, Leonardo Salviati, Daniela Melis, Eliana Di Battista, Alessandra Vancini, Livia Garavelli, Leopoldo Zelante, Giuseppe Merla, Molecular Analysis, Pathogenic Mechanisms, and Readthrough Therapy on a Large Cohort of Kabuki Syndrome Patients, Human Mutation, 2014, 35, 7
  6. 6
    Jake N. Miller, David A. Pearce, Nonsense-mediated decay in genetic disease: Friend or foe?, Mutation Research/Reviews in Mutation Research, 2014, 762, 52

    CrossRef

  7. 7
    Marta Joanna Podralska, Agnieszka Stembalska, Ryszard Ślęzak, Aleksandra Lewandowicz-Uszyńska, Barbara Pietrucha, Sylwia Kołtan, Jadwiga Wigowska-Sowińska, Jacek Pilch, Maria Mosor, Iwona Ziółkowska-Suchanek, Agnieszka Dzikiewicz-Krawczyk, Ryszard Słomski, Ten new ATM alterations in Polish patients with ataxia-telangiectasia, Molecular Genetics & Genomic Medicine, 2014, 2, 6
  8. 8
    Amos Etzioni, Hans D. Ochs, Deborah McCurdy, Richard A. Gatti, Primary Immunodeficiency Disorders, 2014,

    CrossRef

  9. 9
    Simona Cavalieri, Elisa Pozzi, Richard A Gatti, Alfredo Brusco, Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO), European Journal of Human Genetics, 2013, 21, 7, 774

    CrossRef

  10. 10
    Jacob Mallott, Antonia Kwan, Joseph Church, Diana Gonzalez-Espinosa, Fred Lorey, Ling Fung Tang, Uma Sunderam, Sadhna Rana, Rajgopal Srinivasan, Steven E. Brenner, Jennifer Puck, Newborn Screening for SCID Identifies Patients with Ataxia Telangiectasia, Journal of Clinical Immunology, 2013, 33, 3, 540

    CrossRef

  11. 11
    Sarah E. Flanagan, Weijia Xie, Richard Caswell, Annet Damhuis, Christine Vianey-Saban, Teoman Akcay, Feyza Darendeliler, Firdevs Bas, Ayla Guven, Zeynep Siklar, Gonul Ocal, Merih Berberoglu, Nuala Murphy, Maureen O’Sullivan, Andrew Green, Peter E. Clayton, Indraneel Banerjee, Peter T. Clayton, Khalid Hussain, Michael N. Weedon, Sian Ellard, Next-Generation Sequencing Reveals Deep Intronic Cryptic ABCC8 and HADH Splicing Founder Mutations Causing Hyperinsulinism by Pseudoexon Activation, The American Journal of Human Genetics, 2013, 92, 1, 131

    CrossRef

  12. 12
    Maurizio Romano, Emanuele Buratti, Diana Baralle, Role of Pseudoexons and Pseudointrons in Human Cancer, International Journal of Cell Biology, 2013, 2013, 1

    CrossRef

  13. 13
    Peiyee Lee, Nathan T. Martin, Kotoka Nakamura, Soheila Azghadi, Mandana Amiri, Uri Ben-David, Susan Perlman, Richard A. Gatti, Hailiang Hu, William E. Lowry, SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs, Nature Communications, 2013, 4, 1824

    CrossRef

  14. 14
    Mallory A. Havens, Dominik M. Duelli, Michelle L. Hastings, Targeting RNA splicing for disease therapy, Wiley Interdisciplinary Reviews: RNA, 2013, 4, 3
  15. 15
    Yu Huang, Lu Yang, Jianchun Wang, Fan Yang, Ying Xiao, Rongjun Xia, Xianhou Yuan, Mingshan Yan, Twelve Novel Atm Mutations Identified in Chinese Ataxia Telangiectasia Patients, NeuroMolecular Medicine, 2013, 15, 3, 536

    CrossRef

  16. 16
    Hui-Ling Rose Lee, Joseph P. Dougherty, Pharmaceutical therapies to recode nonsense mutations in inherited diseases, Pharmacology & Therapeutics, 2012, 136, 2, 227

    CrossRef

  17. 17
    T. Isoda, M. Takagi, J. Piao, S. Nakagama, M. Sato, K. Masuda, T. Ikawa, M. Azuma, T. Morio, H. Kawamoto, S. Mizutani, Process for immune defect and chromosomal translocation during early thymocyte development lacking ATM, Blood, 2012, 120, 4, 789

    CrossRef

  18. 18
    Richard A. Gatti, SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic models, Annals of the New York Academy of Sciences, 2012, 1250, 1